Priya Rastogi
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 37
Publications (10 Years): 37
Publications
- Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
- Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J TuttPatient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
- Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
- Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
- Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
- Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
- Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J TuttPatient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
- Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
- Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J TuttPatient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
- Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
- Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
- Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J TuttPatient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J TuttPatient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
- Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
- Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
- Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
- Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J TuttPatient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
- Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J TuttPatient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
- Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J TuttPatient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
- Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J TuttPatient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
- Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi